dc.creatorFolschweiller, Nicolas
dc.creatorTeixeira, Julio
dc.creatorJoshi, Smita
dc.creatorGoldani, Luciano Z.
dc.creatorSupparatpinyo, Khuanchai
dc.creatorBasu, Partha
dc.creatorChotpitayasunondh, Tawee
dc.creatorChetchotisakd, Ploenchan
dc.creatorRuxrungtham, Kiat
dc.creatorRoteli-Martins, Cecilia
dc.creatorGrinsztejn, Beatriz
dc.creatorQuintana, Silvana Maria
dc.creatorKumarasamy, Nagalingeswaran
dc.creatorPoongulali, Selvamuthu
dc.creatorKulkarni, Vinay
dc.creatorLin, Lan
dc.creatorDatta, Sanjoy K.
dc.creatorDescamps, Dominique
dc.creatorDodet, Monique
dc.creatorDubin, Gary
dc.creatorFriel, Damien
dc.creatorHezareh, Marjan
dc.creatorKarkada, Naveen
dc.creatorMeric Camilleri, Dorothee
dc.creatorPoncelet, Sylviane
dc.creatorSalaun, Bruno
dc.creatorTavares-da-Silva, Fernanda
dc.creatorThomas-Jooris, Florence
dc.creatorStruyf, Frank
dc.date.accessioned2020-07-27T18:42:41Z
dc.date.accessioned2023-09-05T12:05:03Z
dc.date.available2020-07-27T18:42:41Z
dc.date.available2023-09-05T12:05:03Z
dc.date.created2020-07-27T18:42:41Z
dc.date.issued2020
dc.identifierFOLSCHWEILLER, Nicolas et al. Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15-25 years: A phase IV randomized comparative study. EClinicalMedicine, v. 23, n. 100353, p. 1-16, 2020.
dc.identifier2589-5370
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/42413
dc.identifier10.1016/j.eclinm.2020.100353
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8648995
dc.languageeng
dc.publisherElsevier
dc.rightsrestricted access
dc.titleImmunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15-25 years: A phase IV randomized comparative study
dc.typeArticle


Este ítem pertenece a la siguiente institución